Immunic, Inc. (IMUX) NASDAQ
1.18
-0.04(-3.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.18
-0.04(-3.28%)
Currency In USD
| Market Cap | 830.91M |
| Enterprise Value | 816.11M |
| P/E Ratio | -18.91 |
| PEG Ratio | -0.68 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -275.31 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.03 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -4.04 |
| Return On Equity | -11.98 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -168,000 |
| EBITDA | -97M |
| Net Income | -97.17M |
| Diluted EPS | -0.62 |
| Total Cash | 15.48M |
| Total Cash/Share | 0.01 |
| Total Debt | 684,000 |
| Total Debt/Equity | -0.1 |
| Current Ratio | 0.75 |
| Book Value Per Share | -0 |
| 52-Week Change | 19.43 |
| 52-Week High | 1.51 |
| 52-Week Low | 0.51 |
| Moving Average 50 Days | 1.05 |
| Moving Average 200 Days | 0.85 |
| Average Volume | 3.58M |
| Shares Outstanding | 98.69M |
| % Held by Institutions | 26.45 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | April 15, 2019 |